 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - EAGLE PHARMACEUTICALS Inc (EGRX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-01-02 Sale | 2019-01-04 9:22 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 31,569 | $39.49 | $1,246,763 | 1,518,390 (Direct) | View |
| 2019-02-01 Sale | 2019-02-04 8:04 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 30,085 | $41.54 | $1,249,831 | 1,549,605 (Direct) | View |
| 2019-03-01 Sale | 2019-03-04 4:31 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 24,428 | $51.17 | $1,250,015 | 1,525,177 (Direct) | View |
| 2019-05-09 Sale | 2019-05-13 5:52 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Braunstein Douglas L Director | 159,223 | $56.81 | $9,045,973 | 811,777 (Indirect) | View |
| 2019-09-11 Sale | 2019-09-13 4:43 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director | 1,312 | $60.06 | $78,799 | 810,465 (Indirect) | View |
| 2019-09-17 Sale | 2019-09-19 4:13 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director | 100 | $60 | $6,000 | 810,365 (Indirect) | View |
| 2019-10-07 Sale | 2019-10-09 4:13 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director | 6,459 | $60.09 | $388,119 | 803,906 (Indirect) | View |
| 2019-10-10 Sale | 2019-10-15 6:24 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director | 28,038 | $60.64 | $1,700,257 | 775,868 (Indirect) | View |
| 2019-10-16 Sale | 2019-10-18 5:29 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director | 15,544 | $62.58 | $972,745 | 760,324 (Indirect) | View |
| 2019-10-21 Sale | 2019-10-23 6:58 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director | 10,616 | $62.63 | $664,924 | 749,708 (Indirect) | View |
| 2019-10-24 Sale | 2019-10-28 4:40 pm | EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director | 16,931 | $63.48 | $1,074,715 | 732,777 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-03-30 Exercise | 2018-04-03 5:05 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO | 113,104 | $4.04 | 0 (Direct) | View |
| 2018-03-30 Tax Withholding | 2018-04-03 5:05 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO | 57,895 | $52.69 | 0 (Direct) | View |
| 2018-03-30 Exercise | 2018-04-03 5:05 pm | N/A 2018-10-02 | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO | 113,104 | $4.04 | 0 (Direct) | View |
| 2018-06-28 Exercise | 2018-07-03 5:09 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO | 124,804 | $4.04 | 0 (Direct) | View |
| 2018-06-28 Exercise | 2018-07-03 5:09 pm | N/A 2019-04-02 | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO | 124,804 | $4.04 | 0 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 7:58 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | Edlin Richard A. Director | 10,000 | $42.4 | 10,000 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 8:01 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director | 10,000 | $42.4 | 10,000 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 8:02 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | Glenning Robert Director | 10,000 | $42.4 | 10,000 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 8:03 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | Graves Michael Director | 10,000 | $42.4 | 10,000 (Direct) | View |
| 2019-01-07 Tax Withholding | 2019-01-25 8:04 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer | 771 | $41.33 | 42,500 (Direct) | View |
| 2019-01-07 Option Award | 2019-01-25 8:04 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer | 19,000 | $0 | 42,500 (Direct) | View |
| 2019-01-07 Option Award | 2019-01-25 8:04 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer | 42,500 | $42.4 | 42,500 (Direct) | View |
| 2019-01-07 Tax Withholding | 2019-01-25 8:04 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO | 600 | $41.33 | 43,200 (Direct) | View |
| 2019-01-07 Option Award | 2019-01-25 8:04 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO | 19,300 | $0 | 43,200 (Direct) | View |
| 2019-01-07 Option Award | 2019-01-25 8:04 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO | 43,200 | $42.4 | 43,200 (Direct) | View |
| 2019-01-07 Tax Withholding | 2019-01-25 8:05 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer | 858 | $41.33 | 46,600 (Direct) | View |
| 2019-01-07 Option Award | 2019-01-25 8:05 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer | 20,900 | $0 | 46,600 (Direct) | View |
| 2019-01-07 Option Award | 2019-01-25 8:05 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer | 46,600 | $42.4 | 46,600 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 8:06 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director | 10,000 | $42.4 | 10,000 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 8:07 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 61,300 | $0 | 137,200 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 8:07 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 137,200 | $42.4 | 137,200 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 9:24 pm | N/A 2029-01-23 | EAGLE PHARMACEUTICALS Inc | EGRX | Braunstein Douglas L Director | 10,000 | $42.4 | 10,000 (Direct) | View |
| 2019-03-05 Exercise | 2019-03-06 4:41 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director | 2,340 | $4.04 | 0 (Direct) | View |
| 2019-03-05 Tax Withholding | 2019-03-06 4:41 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director | 204 | $48.89 | 0 (Direct) | View |
| 2019-03-05 Exercise | 2019-03-06 4:41 pm | N/A 2019-03-06 | EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director | 2,340 | $4.04 | 0 (Direct) | View |
| 2019-03-04 Exercise | 2019-03-06 4:42 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director | 2,340 | $4.04 | 0 (Direct) | View |
| 2019-03-04 Exercise | 2019-03-06 4:42 pm | N/A 2019-03-06 | EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director | 2,340 | $4.04 | 0 (Direct) | View |
| 2019-04-01 Sale | 2019-04-03 4:33 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 24,975 | $50.15 | 1,500,202 (Direct) | View |
| 2019-10-08 Option Award | 2019-10-10 08:02 am | N/A 2029-10-08 | EAGLE PHARMACEUTICALS Inc | EGRX | Simpson Jennifer K. Director | 10,000 | $58.88 | 10,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:19 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | Edlin Richard A. Director | 10,000 | $59.79 | 10,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:20 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | Glenning Robert Director | 10,000 | $59.79 | 10,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:21 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | Graves Michael Director | 10,000 | $59.79 | 10,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:22 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer | 24,000 | $0 | 55,000 (Direct) | View |
| 2020-01-05 Tax Withholding | 2020-01-07 6:22 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer | 815 | $57.38 | 55,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:22 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer | 55,000 | $59.79 | 55,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:24 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO | 19,500 | $0 | 48,000 (Direct) | View |
| 2020-01-05 Tax Withholding | 2020-01-07 6:24 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO | 632 | $57.38 | 48,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:24 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO | 48,000 | $59.79 | 48,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:25 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer | 21,500 | $0 | 51,000 (Direct) | View |
| 2020-01-05 Tax Withholding | 2020-01-07 6:25 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer | 904 | $57.38 | 51,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:25 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer | 51,000 | $59.79 | 51,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:26 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director | 10,000 | $59.79 | 10,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:27 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | Simpson Jennifer K. Director | 10,000 | $59.79 | 10,000 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:29 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 58,300 | $0 | 145,700 (Direct) | View |
| 2020-01-05 Option Award | 2020-01-07 6:29 pm | N/A 2030-01-04 | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 145,700 | $59.79 | 145,700 (Direct) | View |
| 2020-01-23 Tax Withholding | 2020-01-27 4:13 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer | 1,630 | $57.98 | 48,784 (Direct) | View |
| 2020-01-23 Tax Withholding | 2020-01-27 4:14 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO | 1,653 | $57.98 | 43,615 (Direct) | View |
| 2020-01-23 Tax Withholding | 2020-01-27 4:15 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer | 1,793 | $57.98 | 49,811 (Direct) | View |
| 2020-01-23 Tax Withholding | 2020-01-27 4:17 pm | N/A N/A | EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO 10% Owner | 7,548 | $57.98 | 1,550,954 (Direct) | View |